Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Chuang J.,,Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells,2009,International Journal of Cancer,56,10.1002/ijc.24563,Taiwan,Article,Tainan,1,Journal,2-s2.0-70249099611
Chintharlapalli S.,,"Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate in colon cancer cells",2009,International Journal of Cancer,102,10.1002/ijc.24530,United States,Article,College Station,1,Journal,2-s2.0-67650142347
Morales A.,,Reactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosis,2009,Journal of Biological Chemistry,34,10.1074/jbc.M806546200,United States,Article,Miami,1,Journal,2-s2.0-67649752330
Straub A.C.,,Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide,2008,Journal of Clinical Investigation,81,10.1172/JCI35092,United States,Article,Pittsburgh,1,Journal,2-s2.0-57449104408
Kumar P.,,Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone,2008,Molecular Cancer Therapeutics,38,10.1158/1535-7163.MCT-08-0287,United States,Article,Ann Arbor,1,Journal,2-s2.0-51049120761
Kang Y.,,The role of p38 MAPK and JNK in arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells,2008,Journal of Cellular Physiology,82,10.1002/jcp.21470,South Korea,Article,Seoul,0,Journal,2-s2.0-49649085319
Chadalapaka G.,,Curcumin decreases specificity protein expression in bladder cancer cells,2008,Cancer Research,143,10.1158/0008-5472.CAN-07-6805,United States,Article,College Station,1,Journal,2-s2.0-48549085442
Mertens-Talcott S.U.,,The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G<inf>2</inf>-M checkpoint in MDA-MB-231 breast cancer cells,2007,Cancer Research,378,10.1158/0008-5472.CAN-07-2416,United States,Article,College Station,1,Journal,2-s2.0-36349001297
Dilda P.,,Arsenical-based cancer drugs,2007,Cancer Treatment Reviews,277,10.1016/j.ctrv.2007.05.001,Australia,Review,Sydney,0,Journal,2-s2.0-34548434715
Ai Z.,,Arsenic trioxide-mediated growth inhibition in gallbladder carcinoma cells via down-regulation of Cyclin D1 transcription mediated by Sp1 transcription factor,2007,Biochemical and Biophysical Research Communications,20,10.1016/j.bbrc.2007.06.123,China,Article,Shanghai,0,Journal,2-s2.0-34447275279
Lu J.,,Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide,2007,Proceedings of the National Academy of Sciences of the United States of America,350,10.1073/pnas.0701549104,Sweden,Article,Stockholm,1,Journal,2-s2.0-34547644483
Chintharlapalli S.,,Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors,2007,Cancer Research,238,10.1158/0008-5472.CAN-06-3735,United States,Article,College Station,1,Journal,2-s2.0-34047261665
Oh J.,,"Downregulation of transcription factor, Sp1, during cellular senescence",2007,Biochemical and Biophysical Research Communications,45,10.1016/j.bbrc.2006.11.118,South Korea,Article,Seoul,0,Journal,2-s2.0-33845769264
Verstovsek S.,,Arsenic derivatives in hematologic malignancies: A role beyond acute promyelocytic leukemia?,2006,Hematological Oncology,39,10.1002/hon.787,United States,Review,Houston,0,Journal,2-s2.0-33845944601
Jin H.,,Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin,2006,Biochemical Pharmacology,49,10.1016/j.bcp.2006.07.026,South Korea,Article,Seoul,0,Journal,2-s2.0-33750003233
Xiao Y.,,Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer,2006,World Journal of Gastroenterology,37,10.3748/wjg.v12.i36.5780,China,Article,Xi'an,1,Journal,2-s2.0-33750121490
Higgins K.,,Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins,2006,Biochemical and Biophysical Research Communications,62,10.1016/j.bbrc.2006.04.111,United States,Article,College Station,0,Journal,2-s2.0-33745771813
Abdelrahim M.,,"Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation",2006,Journal of the National Cancer Institute,136,10.1093/jnci/djj232,United States,Article,College Station,1,Journal,2-s2.0-33745226490
Cheng Y.,,Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells,2006,Archives of Toxicology,30,10.1007/s00204-005-0045-1,Taiwan,Article,Zhunan,0,Journal,2-s2.0-33646564394
Kajiguchi T.,,Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines,2006,Cancer Science,36,10.1111/j.1349-7006.2006.00199.x,Japan,Article,Nagoya,1,Journal,2-s2.0-33744532339
Abdelrahim M.,,Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins,2005,Molecular Pharmacology,105,10.1124/mol.105.011825,United States,Article,College Station,0,Journal,2-s2.0-23044452436
Chou W.,,Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation,2005,Blood,64,10.1182/blood-2005-01-0241,Taiwan,Article,Taipei,0,Journal,2-s2.0-22044440559
Han S.S.,,"Arsenic trioxide represses constitutive activation of NF-κB and COX-2 expression in human acute myeloid leukemia, HL-60",2005,Journal of Cellular Biochemistry,45,10.1002/jcb.20337,South Korea,Article,Suwon,0,Journal,2-s2.0-21744458775
Hu J.,,Arsenic in cancer therapy,2005,Anti-Cancer Drugs,54,10.1097/00001813-200502000-00002,China,Review,Shanghai,0,Journal,2-s2.0-13844281112
Soucy N.V.,,Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice,2005,Cardiovascular Toxicology,52,10.1385/ct:5:1:029,United States,Article,Hanover,0,Journal,2-s2.0-18544372749
Abdelrahim M.,,Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells,2004,Cancer Research,163,10.1158/0008-5472.CAN-04-0713,United States;United States,Article,College Station;College Station,1,Journal,2-s2.0-4644274880
Yao J.,,"Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer",2004,Clinical Cancer Research,162,10.1158/1078-0432.CCR-03-0628,United States,Article,Houston,1,Journal,2-s2.0-3042570272
Hosoi Y.,,Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer.,2004,International journal of oncology,137,10.3892/ijo.25.2.461,Japan,Article,Tokyo,0,Journal,2-s2.0-16644391541
Wang L.,,Transcription Factor Sp1 Expression Is a Significant Predictor of Survival in Human Gastric Cancer,2003,Clinical Cancer Research,272,,United States,Article,Houston,0,Journal,2-s2.0-0348223971
Soucy N.,,Arsenic stimulates angiogenesis and tumorigenesis in vivo,2003,Toxicological Sciences,110,10.1093/toxsci/kfg231,United States,Article,Hanover,1,Journal,2-s2.0-0347660925
Shen Z.Y.,,The inhibition of growth and angiogenesis in heterotransplanted esophageal carcinoma via intratumoral injection of arsenic trioxide.,Nov-Dec,Oncology reports,21,10.3892/or.10.6.1869,China,Article,Shantou,0,Journal,2-s2.0-2642585106
Chiefari E.,,Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: A role in NIS expression regulation?,2002,BMC Cancer,91,10.1186/1471-2407-2-35,Italy,Article,Catanzaro,1,Journal,2-s2.0-3042752956
Bouwman P.,,Regulation of the activity of Sp1-related transcription factors,2002,Molecular and Cellular Endocrinology,380,10.1016/S0303-7207(02)00221-6,Netherlands,Review,Utrecht,0,Journal,2-s2.0-0037201722
Miller W.,,Mechanisms of action of arsenic trioxide,2002,Cancer Research,801,,Canada,Review,Montreal,0,Journal,2-s2.0-0037099645
Abdelrahim M.,,Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells.,2002,The Journal of biological chemistry,105,10.1074/jbc.M203828200,United States,Article,College Station,1,Journal,2-s2.0-0037047327
Roboz G.J.,,Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis,2000,Blood,252,10.1182/blood.v96.4.1525,United States,Article,New York,1,Journal,2-s2.0-0034663032
Shen Z.Y.,,The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells.,2000,International journal of molecular medicine,82,10.3892/ijmm.5.2.155,China,Article,Shantou,0,Journal,2-s2.0-0034133665
Yang C.,,Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells,1999,British Journal of Cancer,128,10.1038/sj.bjc.6690766,Taiwan,Article,Taipei,1,Journal,2-s2.0-0032718622
Larochette N.,,Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore,1999,Experimental Cell Research,279,10.1006/excr.1999.4519,France,Article,Paris,0,Journal,2-s2.0-0033563729
Kroemer G.,,"Arsenic trioxide, a novel mitochondriotoxic anticancer agent?",1999,Journal of the National Cancer Institute,81,10.1093/jnci/91.9.743,France,Editorial,Paris,1,Journal,2-s2.0-0033526398
Zhu X.H.,,Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations,1999,Journal of the National Cancer Institute,262,10.1093/jnci/91.9.772,,Article,,1,Journal,2-s2.0-0033526358
Rickers A.,,Cleavage of transcription factor SP1 by caspases during anti-IgM- induced B-cell apoptosis,1999,European Journal of Biochemistry,38,10.1046/j.1432-1327.1999.00273.x,Germany,Article,Berlin,0,Journal,2-s2.0-0033118849
Chen Y.,,Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis,1998,Journal of Cellular Physiology,404,10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9,Taiwan,Article,Taipei,0,Journal,2-s2.0-0031657760
Shao W.,,Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells,1998,Journal of the National Cancer Institute,316,10.1093/jnci/90.2.124,Canada,Article,Montreal,1,Journal,2-s2.0-0000531696
Chen G.Q.,,Use of arsenic trioxide (As<inf>2</inf>O<inf>3</inf>) in the treatment of acute promyelocytic leukemia (APL): I. As<inf>2</inf>O<inf>3</inf> exerts dose-dependent dual effects on APL cells,1997,Blood,723,,China,Article,Shanghai,0,Journal,2-s2.0-0030610686
Shen Z.X.,,Use of arsenic trioxide (As<inf>2</inf>O<inf>3</inf>) in the treatment of acute promyelocytic leukemia (AFL): II. Clinical efficacy and pharmacokinetics in relapsed patients,1997,Blood,1233,,,Article,,0,Journal,2-s2.0-0030610687
Chan P.C.,,"Arsenic carcinogenesis in animals and in humans: Mechanistic, experimental, and epidemiological evidence",1997,Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews,102,10.1080/10590509709373492,United States,Review,Research Triangle Park,0,Journal,2-s2.0-0031449819
Piedrafita F.,,Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation,1997,Molecular and Cellular Biology,128,10.1128/MCB.17.11.6348,United States,Article,San Diego,1,Journal,2-s2.0-0030799123
Chen G.Q.,,In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As<inf>2</inf>O<inf>3</inf>) in the treatment of acute promyelocytic leukemia: As<inf>2</inf>O<inf>3</inf> induces NB<inf>4</inf> cell apoptosis with downregulation of Bcl-2 expression and modulation of PML- RARα/PML proteins,1996,Blood,763,10.1182/blood.v88.3.1052.bloodjournal8831052,,Article,,1,Journal,2-s2.0-0010740572
Ammendola R.,,Sp1 DNA binding efficiency is highly reduced in nuclear extracts from aged rat tissues,1992,Journal of Biological Chemistry,117,,Italy,Article,Naples,0,Journal,2-s2.0-0026644408
Borrow J.,,Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17,1990,Science,527,10.1126/science.2218500,United Kingdom,Article,London,0,Journal,2-s2.0-0025089467
De Thé H.,,The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus,1990,Nature,1124,10.1038/347558a0,France,Article,Paris,0,Journal,2-s2.0-0025043959
